Arama

Atomoxetine-Induced Mania in a 6-year-old Child with Autism Spectrum Disorder

Yasar Tanir, Gaye Turkmen

( Psychiatry and Clinical Psychopharmacology 2020; 30: 464-466) DOI: 10.5455/PCP.20201009072139

Abstract Full Text ( PDF) Related Articles

Insignificant Effects of Atomoxetine on Thyroid Functions in Children and Adolescents with Attention Deficit and Hyperactivity Disorder in Short Term

Canan Tanidir, Ibrahim Tanidir, Kayhan Bahali, Hatice Gunes, Hilal Adaletli, Erkut Ozturk, Tolga Unuvar, Ozden Uner

( Psychiatry and Clinical Psychopharmacology 2016; 26: 58-63) DOI: 10.5455/bcp.20150505104526

Abstract Full Text ( PDF) Related Articles

Attention Deficit Hyperactivity Disorder Treatment Practice in Turkey

Ozgur Oner, Hakan Turkcapar, Fatma Isli, Hasan Karadag, Akif Akbulat, Ali Basci, Mesil Aksoy, Cem Seckin, Ali Alkan

( Psychiatry and Clinical Psychopharmacology 2016; 26: 265-272) DOI: 10.5455/bcp.20151202103706

Abstract Full Text ( PDF) Related Articles

Acute Urinary Retention Associated with Increased Dose of Atomoxetine in a Child: A Case Report

Caner Mutlu, Ozgur Yorbik, Hamiyet Ipek, Ilhan Tanju

( Psychiatry and Clinical Psychopharmacology 2015; 25: 299-301) DOI: 10.5455/bcp.20140408015727

Abstract Full Text ( PDF) Related Articles

Should immediate release methylphenidate be the treatment of choice for initiation of ADHD treatment?

Veli Yidirim, Yunus Killi, Serkan Gunes, Recep Bostan, Fevziye Toros

( Psychiatry and Clinical Psychopharmacology 2015; 25: S160-S160)

Abstract Full Text ( PDF) Related Articles

Probable emergence of symptoms of trichotillomania by atomoxetine: a case report

Hamza Ayaydın

( Psychiatry and Clinical Psychopharmacology 2019; 29: 220-222) DOI: 10.1080/24750573.2018.1439601

Abstract Full Text ( PDF) Related Articles

The effects of atomoxetine on weight, height, and body mass index in Turkish children and adolescents with attention deficit hyperactivity disorder

Serkan Turan, Aynur Pekcanlar

( Psychiatry and Clinical Psychopharmacology 2019; 29: 781-786) DOI: 10.1080/24750573.2019.1637393

Abstract Full Text ( PDF) Related Articles

Maintenance of effect in Attention Deficit Hyperactivity Disorder: what do placebo-controlled randomized withdrawal studies of atomoxetine and stimulants tell us?

Hasan Peksel, Himanshu Upadhyaya, David H. Adams, Yoko Tanaka, Virginia S. Haynes, Rodrigo Escobar, Michael Colla

( Psychiatry and Clinical Psychopharmacology 2015; 25: S82-S82)

Abstract Full Text ( PDF) Related Articles

Improving effect of atomoxetine and reboxetine on memory in passive avoidance task

Murat Yuce, Fatih Ilkaya, Koray Karabekiroglu, Gokce Say, Mahmut Mujdeci, Filiz Bayril, Arzu Agri, Hasan Guzel, Faruk Aydin

( Psychiatry and Clinical Psychopharmacology 2014; 24: 211-219) DOI: 10.5455/bcp.20140211010550

Abstract Full Text ( PDF) Related Articles

Atomoxetine induced suicidal ideation: case report

( Psychiatry and Clinical Psychopharmacology 2014; 24: S347-S347)

Abstract Related Articles

Atomoxetine use in Attention deficit hyperactivity disorder and comorbid tic disorder in PANDAS: two case reports

( Psychiatry and Clinical Psychopharmacology 2014; 24: S321-S321)

Abstract Related Articles

Combined methylphenidate and atomoxetine therapy in attention deficit hyperactivity disorder; a retrospective study

( Psychiatry and Clinical Psychopharmacology 2014; 24: S319-S319)

Abstract Related Articles

Atomoxetine-induced dose-dependent bruxism in a child patient

( Psychiatry and Clinical Psychopharmacology 2014; 24: S267-S267)

Abstract Related Articles

What is the effect of atomoxetine on epilepsy in a boy with attention deficit-hyperactivity disorder?

( Psychiatry and Clinical Psychopharmacology 2014; 24: S232-S233)

Abstract Related Articles

Treatment choice in association of attention deficit-hyperactivity disorder with Williams and Moebius Syndromes: case reports

( Psychiatry and Clinical Psychopharmacology 2014; 24: S226-S226)

Abstract Related Articles

Effects of atomoxetine on depression and anxiety symptoms in children with attention deficit-hyperactivity disorder: preliminary findings of a prospective, open-label study

( Psychiatry and Clinical Psychopharmacology 2014; 24: S225-S225)

Abstract Related Articles

Usage of atomoxetine for encopresis and attention deficit-hyperactivity disorder

( Psychiatry and Clinical Psychopharmacology 2014; 24: S200-S200)

Abstract Related Articles

Leukopenia due to atomoxetine use: a case report

( Psychiatry and Clinical Psychopharmacology 2014; 24: S196-S196)

Abstract Related Articles

Motor tics due to atomoxetine use: a case report

Mustafa Küçükköse, Nazlı Özbaran, Sezen Gökçen

( Psychiatry and Clinical Psychopharmacology 2011; 21: 364-367) DOI: 10.5455/bcp.20110429040705

Abstract Full Text ( PDF) Related Articles

Atomoxetine-related hair loss in a teenager: a case report

Mehmet Ceylan, Ozhan Yalcin

( Psychiatry and Clinical Psychopharmacology 2010; 20: 258-260)

Abstract Full Text ( PDF) Related Articles

Recent advances in the psychopharmacology of attention deficit hyperactivity disorder

Cem Şengül, Ceyhan Şengül, Emine Öztürk, Nesrin Dilbaz

( Psychiatry and Clinical Psychopharmacology 2005; 15: 192-197)

Abstract Full Text ( PDF) Related Articles

Psychopharmacology Treatment of skin picking behavior with atomoxetine: a case with corpus callosum agenesis and ADHD

( Psychiatry and Clinical Psychopharmacology 2013; 23: S287-S288)

Abstract Related Articles

Psychopharmacology Angioedema induced by atomoxetine: a case report

( Psychiatry and Clinical Psychopharmacology 2013; 23: S271-S272)

Abstract Related Articles

Childhood and adolescence disorders Treatment with atomoxetine: a case with Williams syndrome

( Psychiatry and Clinical Psychopharmacology 2013; 23: S202-S203)

Abstract Related Articles

Childhood and adolescence disorders Mydriasis after initiating therapy with atomoxetine in a boy with juvenile osteopetrosis: a case report

( Psychiatry and Clinical Psychopharmacology 2013; 23: S194-S195)

Abstract Related Articles

Psychopharmacology Atomoxetine induced hypomania-like symptoms in a pre-adolescent patient

( Psychiatry and Clinical Psychopharmacology 2013; 23: S191-S191)

Abstract Related Articles

Childhood and adolescence disorders Pre-treatment and post-treatment Tc-99m TRODAT-1 brain spect findings in three patients with attention deficit and hyperactivity disorder, who were treated by 2-month- atomoxetine treatment

( Psychiatry and Clinical Psychopharmacology 2013; 23: S158-S158)

Abstract Related Articles

Psychopharmacology Atomoxetine-induced bruxism

( Psychiatry and Clinical Psychopharmacology 2013; 23: S119-S119)

Abstract Related Articles

Psychopharmacology Atomoxetine-induced mydriasis in a child

( Psychiatry and Clinical Psychopharmacology 2013; 23: S119-S119)

Abstract Related Articles

Childhood and adolescence disorders Treatment of children with autism spectrum disorders and co-existing attention deficit hyperactivity disorder, with atomoxetine: a retrospective study

( Psychiatry and Clinical Psychopharmacology 2013; 23: S103-S103)

Abstract Related Articles

Psychopharmacology Atomoxetine and methylphenidate for the treatment of attention deficit hyperactivity disorder: a six-month follow-up study

( Psychiatry and Clinical Psychopharmacology 2013; 23: S90-S91)

Abstract Related Articles

Atomoxetine for the treatment of ADHD in young adults with an assessment of associated functional outcomes

( Psychiatry and Clinical Psychopharmacology 2011; 21: -)

Abstract Related Articles

Treatment compliance in children and adolescents initiated on attention deficit/ hyperactivity disorder (ADHD) medication in clinical practice (COMPLY)

Peter M. Wehmeier, Deborah Quai, Ralf W. Dittmann, Tobias Banaschewski, Murat Altın

( Psychiatry and Clinical Psychopharmacology 2012; 22: S108-S108)

Abstract Full Text ( PDF) Related Articles